HTB: no. 12 – plus HIV and COVID-19 (Dec 2021)
20 December 2021. Related: Editorial.
2021
18th International European AIDS Conference (EACS 2021)
20 December 2021. Related: Conference reports.
EACS case study: how to diagnose HIV on PrEP – stopping PrEP or intensify to ART?
20 December 2021. Related: Conference reports, HIV prevention and transmission.
European AIDS Clinical Society honours Simon Collins for longstanding contribution to the field of HIV
20 December 2021. Related: Conference reports, Treatment advocacy.
The importance of confirming screening test results for diabetes and hypertension
20 December 2021. Related: Coinfections and complications.
Selected islatravir studies stop enrolment: further complications with important investigational drugs
20 December 2021. Related: Antiretrovirals.
ECG abnormalities reported by 44% of people older than 40 on ART: results from REPRIEVE study
20 December 2021. Related: Coinfections and complications.
Rare cases of PML diagnosed at CD4 >200 with undetectable viral load
20 December 2021. Related: Coinfections and complications.
FDA further limit use of islatravir in ongoing studies
20 December 2021. Related: Antiretrovirals.
US FDA approves long-acting cabotegravir injections for PrEP: price set at $22,000 a year
20 December 2021. Related: HIV prevention and transmission.
56 Dean Street reports M184V common with recent low adherence to PrEP and seven transmissions with good adherence
20 December 2021. Related: HIV prevention and transmission.
Reducing the risk of COVID-19 in research that involves interrupting ART
20 December 2021. Related: Cure-related research, COVID-19.
Right to Try: activists challenge a flawed film about a potential HIV cure
20 December 2021. Related: Book and film reviews.
New BHIVA statements on HIV and COVID-19 (December 2021)
20 December 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Myocarditis and pericarditis after COVID-19 vaccines
20 December 2021. Related: COVID-19: vaccine research, COVID-19.
WHO advises against use of convalescent plasma for COVID-19
20 December 2021. Related: COVID-19: investigational drugs, COVID-19.
HTB: no. 12 – plus HIV and COVID-19 (20 December 2021)
20 December 2021. Related: PDFs.
IAS strategy for an HIV cure (2021): easy-to-read Q&A
1 December 2021. Related: Cure-related research.
HTB: no. 11 – plus HIV and COVID-19 (Nov/Dec 2021)
30 November 2021. Related: Editorial.
IAS review on HIV cure research: A global scientific strategy to cure HIV (2021)
30 November 2021. Related: Editorial.
18th International European AIDS Conference (EACS 2021)
30 November 2021. Related: Conference reports.
Lenacapavir: drug resistance after viral rebound in treatment experienced participants
30 November 2021. Related: Conference reports, Antiretrovirals, Drug resistance.
Implications of historical M184V on use of dual dolutegravir/lamivudine ART
30 November 2021. Related: Conference reports, Antiretrovirals, Drug resistance.
Stopping long-acting cabotegravir/rilpivirine: 1 in 5 trial participants didn’t restart oral ART within eight weeks
30 November 2021. Related: Conference reports, Antiretrovirals.
Islatravir plus doravirine dual ART: 144 week follow-up from phase 2 study
30 November 2021. Related: Conference reports, Antiretrovirals.
HIV-specific mental health services across the EU
30 November 2021. Related: Conference reports, Coinfections and complications.
NICE approves long-acting cabotegravir and rilpivirine injections in England and Wales
30 November 2021. Related: Antiretrovirals, Treatment access.
MSD/Merck stop once-weekly NNRTI MK-8507: islatravir studies continue with closer monitoring
30 November 2021. Related: Antiretrovirals.
UK oral history project for young people who were born with HIV
30 November 2021. Related: Other news.
Colchicine: no clinical benefits against COVID-19 in pooled analysis of RCTs
30 November 2021. Related: COVID-19: investigational drugs, COVID-19.
Eli Lilly withdraw EU application for bNAbs etesevimab and bamlanivimab
30 November 2021. Related: COVID-19: investigational drugs, COVID-19.
HTB: no. 11 – plus HIV and COVID-19 (30 November 2021)
30 November 2021. Related: PDFs.
HTB: no. 10 – plus HIV and COVID-19 (31 October 2021)
31 October 2021. Related: Editorial.
18th International European AIDS Conference (EACS 2021)
31 October 2021. Related: Conference reports.
EACS 2021: a call for collaborations and for both HIV and COVID-19
31 October 2021. Related: Conference reports, Treatment strategies, HIV prevention and transmission.
Reduced responses to COVID-19 vaccines at low CD4 counts
31 October 2021. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19.
EACS Guidelines: 11th edition (October 2021)
31 October 2021. Related: Conference reports, Guidelines.
Community “Respect my HIV” march: 30 October 2021 in London
31 October 2021. Related: Conference reports, Treatment advocacy.
NHS Scotland approves long-acting cabotegravir and rilpivirine injections
31 October 2021. Related: Antiretrovirals.
Early treatment prevents anal cancer in people living with HIV: ANCHOR study stops early
31 October 2021. Related: Cancer and HIV.
Benefits reported for continued use of cotrimoxazole prophylaxis at high CD4 counts in Malawi
31 October 2021. Related: Coinfections and complications.
Gilead withdraws application for F/TAF as PrEP in the EU
31 October 2021. Related: HIV prevention and transmission.
BHIVA guidelines for the management of HIV-2 (2021)
31 October 2021. Related: Guidelines, Coinfections and complications.
Explaining rare cases of HIV remission – and risk of viral rebound after many years off-ART
31 October 2021. Related: Cure-related research.
CHAI 2021 HIV market report: the state of the HIV market in low- and middle-income countries
31 October 2021. Related: On the web.
Continued evidence for poorer COVID-19 outcomes in people with HIV
31 October 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Immune responses to natural COVID-19 infection in HIV positive people
31 October 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Durability of immune responses to COVID-19 vaccines in HIV positive people
31 October 2021. Related: COVID-19: vaccine research, COVID-19.
Sputnik V vaccine not approved in South Africa due to potential increased risk of HIV
31 October 2021. Related: COVID-19: vaccine research, COVID-19.
Sanofi reports phase 1/2 mRNA results but withdraws from further COVID19 vaccines
31 October 2021. Related: COVID-19: vaccine research, COVID-19.
Early efficacy results with oral molnupiravir focuses attention on price and access
31 October 2021. Related: COVID-19: treatment access, COVID-19: investigational drugs, COVID-19.
HTB: no. 10 – plus HIV and COVID-19 (31 October 2021)
31 October 2021. Related: PDFs.
HTB: no. 9 – plus HIV and COVID-19 (17 September 2021)
17 September 2021. Related: Editorial.
11th IAS Conference on HIV Science (IAS 2021)
17 September 2021. Related: Conference reports.
IAS 2021 website now open access
17 September 2021. Related: Conference reports, On the web.
Substudies from the ODYSSEY trial: results July 2021
17 September 2021. Related: Conference reports, Paediatric care.
Trial design for next generation PrEP
17 September 2021. Related: Conference reports.
Lenacapavir submitted to EMA for MDR HIV
17 September 2021. Related: Antiretrovirals.
Pipeline report 2021: HIV drugs in development
17 September 2021. Related: Special reports, Supplements, Pipeline report, Antiretrovirals.
Darunavir/ritonavir price now US $210 for global access
17 September 2021. Related: Treatment access.
HPV vaccine prevent penile infections in young gay men
17 September 2021. Related: Coinfections and complications.
Imbokodo trial results highlight challenge of developing an HIV vaccine and urgent need for access to proven prevention tools
17 September 2021. Related: HIV prevention and transmission, Vaccines and microbicides.
Moderna registers HIV vaccine study
17 September 2021. Related: HIV prevention and transmission, Vaccines and microbicides.
START study: call for participants to attend final visit – please help…
17 September 2021. Related: Research studies.
New COVID-19 vaccine information from Modern ART for South Africa
17 September 2021. Related: COVID-19: HIV and COVID-19 coinfection.